论文信息 - Preclinical assessment of a new recombinant ADAMTS‐13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura - 字舞流文

Preclinical assessment of a new recombinant ADAMTS‐13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura

F. Horling | B. Dietrich | F. Scheiflinger | C. Piskernik | B. Plaimauer | E. Muchitsch | G. Höbarth | T. Ruthsatz | K. Benamara | W. Höllriegl | A. Kopić | M. Turecek